NYSE · NMR

Nomura Holdings, Inc.

$9.79 -$0.02 (-0.20%) 1D After hours
Session Pulse After hours chatter is way louder than usual 3 mentions today 1 SEC filing since Tue close 4 Full pulse →

Key Metrics

$28.67B
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield 626.8%
Free cash flow −$1.20T
Beta · 1Y 1.31
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 28
    6 insider transaction filings hit the record.

    Form 4s are events, not verdicts — officers, directors, and 10% owners reporting their own trades. The forms post hours before the media writes them up.

    RECEIPT: SEC FORM 4 × 6, TIMESTAMPED
  • Jul 28
    Chatter ran way louder than usual.

    3 mentions across the stream that day (+5.8σ vs its own baseline) — attention, not direction. Loud days mark where the crowd was looking.

    RECEIPT: NARRATIVE VELOCITY, 30-DAY BASELINE
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$28.67B
Enterprise value$11.27T
Shares outstanding2.9B
52-wk range$6.59 – $10.06
Avg volume · 20D1.4M
Net cash −$11.25T
Book value / share$1,268.53
ExchangeNYSE
About Nomura Holdings, Inc.
IPO dateMay 16, 1995
Employees28677

Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions world-wide, including Japan, the U.S., the U.K., Singapore, and the Hong Kong Special Administrative Region ("Hong Kong") through its subsidiaries.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio
Quick ratio
Debt / equity4.19
Debt / EBITDA
Net cash −$11.25T
Working capital

Cash Flow · TTM

Operating CF −$842.96B
Capex −$353.82B
Free cash flow −$1.20T
Buybacks $101.50B
Dividends paid $179.74B
Shareholder yield 980.8%

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings